Sex differences in the hepatic cholesterol sensing mechanisms in mice

Molecules

Volumn 18, Issue 9, 2013, Pages 11067-11085

  Lorbek, Gregor ^a   Perše, Martina ^a   Horvat, Simon ^a,b   Björkhem, Ingemar ^c   Rozman, Damjana ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bile acid; Cholesterol synthesis; Gene expression; High fat diet; Liver; Mouse; Sterol

Indexed keywords

BILE ACID; CHOLESTEROL; MESSENGER RNA; TRANSCRIPTOME;

129 MOUSE; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; FEMALE; GALLBLADDER; GENE EXPRESSION REGULATION; GENETICS; LIPID DIET; LIPID METABOLISM; LIVER; LOW FAT DIET; MALE; METABOLISM; MOUSE; SEXUAL DEVELOPMENT;

ANIMALS; BILE ACIDS AND SALTS; BIOSYNTHETIC PATHWAYS; CHOLESTEROL; DIET, FAT-RESTRICTED; DIET, HIGH-FAT; FEMALE; GALLBLADDER; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; RNA, MESSENGER; SEX CHARACTERISTICS; TRANSCRIPTOME;

EID: 84885095863     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules180911067     Document Type: Article

References (64)

1. Ramasubbu, K.; Gurm, H.; Litaker, D. Gender bias in clinical trials: do double standards still apply? J. Womens Health Gend. Based Med. 2001, 10, 757-764. (Pubitemid 33062085)
2. Pilote, L.; Dasgupta, K.; Guru, V.; Humphries, K.H.; McGrath, J.; Norris, C.; Rabi, D.; Tremblay, J.; Alamian, A.; Barnett, T.; et al. A comprehensive view of sex-specific issues related to cardiovascular disease. Can. Med. Assn. J. 2007, 176, S1-S44.
3. Kautzky-Willer, A.; Handisurya, A. Metabolic diseases and associated complications: Sex and gender matter! Eur. J. Clin. Invest. 2009, 39, 631-648.
4. Lleo, A.; Battezzati, P.M.; Selmi, C.; Gershwin, M.E.; Podda, M. Is autoimmunity a matter of sex? Autoimmun. Rev. 2008, 7, 626-630.
5. Trapani, L.; Pallottini, V. Age-related hypercholesterolemia and hmg-coa reductase dysregulation: sex does matter (a gender perspective). Curr. Gerontol. Geriatr. Res. 2010, 2010, 420139.
6. Nagoshi, S. Sex- or gender-specific medicine in hepatology. Hepatol. Res. 2008, 38, 219-224. (Pubitemid 351193949)
7. Rozman, D.; Monostory, K. Perspectives of the non-statin hypolipidemic agents. Pharmacol. Ther. 2010, 127, 19-40.
8. Thacker, H.L. Sex, Statins, and diabetes. Cleve. Clin. J. Med. 2013, 80, 187-187.
9. Fon Tacer, K.; Rozman, D. Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. J. Lipids 2011, 2011, 1-14.
10. Lorbek, G.; Rozman, D. Cholesterol and Inflammation at the Crossroads of Non-Alcoholic Fatty Liver Disease (NAFLD) and Atherogenesis. In Atherogenesis; Parthasarathy, S., Ed.; InTech: Rijeka, Croatia, 2012; pp. 281-304.
11. Zhang, H.; He, S.M.; Sun, J.; Wang, C.; Jiang, Y.F.; Gu, Q.; Feng, X.W.; Du, B.; Wang, W.; Shi, X.D.; et al. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China. Int. J. Med. Sci. 2011, 8, 254-262.
12. Pinidiyapathirage, M.J.; Dassanayake, A.S.; Rajindrajith, S.; Kalubowila, U.; Kato, N.; Wickremasinghe, A.R.; de Silva, H.J. Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka. BMC Res. Notes 2011, 4, 513.
13. Denzer, C.; Thiere, D.; Muche, R.; Koenig, W.; Mayer, H.; Kratzer, W.; Wabitsch, M. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J. Clin. Endocrinol. Metab. 2009, 94, 3872-3881.
14. Fernandes, M.T.; Ferraro, A.A.; de Azevedo, R.A.; Fagundes Neto, U. Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, As detected by ultrasound. Acta Paediatr. 2010, 99, 1218-1223.
15. Ayonrinde, O.T.; Olynyk, J.K.; Beilin, L.J.; Mori, T.A.; Pennell, C.E.; de Klerk, N.; Oddy, W.H.; Shipman, P.; Adams, L.A. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011, 53, 800-809.
16. Kirsch, R.; Clarkson, V.; Shephard, E.G.; Marais, D.A.; Jaffer, M.A.; Woodburne, V.E.; Kirsch, R.E.; Hall Pde, L. Rodent nutritional model of non-alcoholic steatohepatitis: Species, Strain and sex difference studies. J. Gastroenterol. Hepatol. 2003, 18, 1272-1282. (Pubitemid 37464002)
17. Spruss, A.; Henkel, J.; Kanuri, G.; Blank, D.; Puschel, G.P.; Bischoff, S.C.; Bergheim, I. Female mice are more susceptible to nonalcoholic fatty liver disease: Sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, But not the hepatic endotoxin response. Mol. Med. 2012, 18, 1346-1355.
18. Comhair, T.M.; Garcia Caraballo, S.C.; Dejong, C.H.; Lamers, W.H.; Kohler, S.E. Dietary cholesterol, Female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat. Nutr. Metab. (Lond) 2011, 8, 4.
19. Larter, C.Z.; Yeh, M.M. Animal models of NASH: getting both pathology and metabolic context right. J. Gastroenterol. Hepatol. 2008, 23, 1635-1648.
20. Dietschy, J.M.; Turley, S.D. Control of cholesterol turnover in the mouse. J. Biol. Chem. 2002, 277, 3801-3804. (Pubitemid 34968627)
21. Jolley, C.D.; Dietschy, J.M.; Turley, S.D. Genetic differences in cholesterol absorption in 129/Sv and C57BL/6 mice: effect on cholesterol responsiveness. Am. J. Physiol. 1999, 276, G1117-G1124. (Pubitemid 29251909)
22. Carlson, S.E.; Mitchell, A.D.; Carter, M.L.; Goldfarb, S. Evidence that physiologic levels of circulating estrogens and neonatal sex-imprinting modify postpubertal hepatic microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Biochim. Biophys. Acta 1980, 633, 154-161. (Pubitemid 11162432)
23. Kojima, M.; Degawa, M. Gender-related difference in altered gene expression of a sterol regulatory element binding protein, SREBP-2, by lead nitrate in rats: correlation with development of hypercholesterolemia. J. Appl. Toxicol. 2006, 26, 381-384. (Pubitemid 44064937)
24. Hewitt, K.N.; Boon, W.C.; Murata, Y.; Jones, M.E.; Simpson, E.R. The aromatase knockout mouse presents with a sexually dimorphic disruption to cholesterol homeostasis. Endocrinology 2003, 144, 3895-3903. (Pubitemid 37088744)
25. De Marinis, E.; Martini, C.; Trentalance, A.; Pallottini, V. Sex differences in hepatic regulation of cholesterol homeostasis. J. Endocrinol. 2008, 198, 635-643.
26. Conforto, T.L.; Waxman, D.J. Sex-specific mouse liver gene expression: genome-wide analysis of developmental changes from pre-pubertal period to young adulthood. Biol. Sex Differ. 2012, 3, 9.
27. Yang, X.; Schadt, E.E.; Wang, S.; Wang, H.; Arnold, A.P.; Ingram-Drake, L.; Drake, T.A.; Lusis, A.J. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome. Res. 2006, 16, 995-1004. (Pubitemid 44162259)
28. Gatti, D.M.; Zhao, N.; Chesler, E.J.; Bradford, B.U.; Shabalin, A.A.; Yordanova, R.; Lu, L.; Rusyn, I. Sex-specific gene expression in the BXD mouse liver. Physiol. Genomics. 2010, 42, 456-468.
29. Maxwell, K.N.; Soccio, R.E.; Duncan, E.M.; Sehayek, E.; Breslow, J.L. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J. Lipid. Res. 2003, 44, 2109-2119. (Pubitemid 37509626)
30. Zhang, Y.; Klein, K.; Sugathan, A.; Nassery, N.; Dombkowski, A.; Zanger, U.M.; Waxman, D.J. Transcriptional profiling of human liver identifies sex-biased genes associated with polygenic dyslipidemia and coronary artery disease. PLoS One 2011, 6, e23506.
31. Acimovic, J.; Rozman, D. Steroidal triterpenes of cholesterol synthesis. Molecules 2013, 18, 4002-4017.
32. Goldstein, J.L.; DeBose-Boyd, R.A.; Brown, M.S. Protein sensors for membrane sterols. Cell 2006, 124, 35-46.
33. Goldstein, J.L.; Brown, M.S. The LDL receptor. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 431-438.
34. Zhao, C.; Dahlman-Wright, K. Liver X receptor in cholesterol metabolism. J. Endocrinol. 2010, 204, 233-240.
35. Repa, J.J.; Berge, K.E.; Pomajzl, C.; Richardson, J.A.; Hobbs, H.; Mangelsdorf, D.J. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 2002, 277, 18793-18800. (Pubitemid 34952438)
36. Wiersma, H.; Gatti, A.; Nijstad, N.; Oude Elferink, R.P.; Kuipers, F.; Tietge, U.J. Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. Hepatology 2009, 50, 1263-1272.
37. Stahlberg, N.; Rico-Bautista, E.; Fisher, R.M.; Wu, X.; Cheung, L.; Flores-Morales, A.; Tybring, G.; Norstedt, G.; Tollet-Egnell, P., Female-predominant expression of fatty acid translocase/CD36 in rat and human liver. Endocrinology 2004, 145, 1972-1979. (Pubitemid 38404293)
38. Henkel, A.S.; Anderson, K.A.; Dewey, A.M.; Kavesh, M.H.; Green, R.M. A chronic high-cholesterol diet paradoxically suppresses hepatic CYP7A1 expression in FVB/NJ mice. J. Lipid. Res. 2011, 52, 289-298.
39. Zaczek, D.; Hammond, J.; Suen, L.; Wandji, S.; Service, D.; Bartke, A.; Chandrashekar, V.; Coschigano, K.; Kopchick, J. Impact of growth hormone resistance on female reproductive function: new insights from growth hormone receptor knockout mice. Biol. Reprod. 2002, 67, 1115-1124.
40. Horton, J.D.; Shah, N.A.; Warrington, J.A.; Anderson, N.N.; Park, S.W.; Brown, M.S.; Goldstein, J.L. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA 2003, 100, 12027-12032. (Pubitemid 37271509)
41. Dietschy, J.M.; Turley, S.D.; Spady, D.K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid. Res. 1993, 34, 1637-1659. (Pubitemid 23298709)
42. Boone, L.R.; Brooks, P.A.; Niesen, M.I.; Ness, G.C. Mechanism of resistance to dietary cholesterol. J. Lipids 2011, 2011, 101242.
43. Jo, Y.; Debose-Boyd, R.A. Control of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase. Crit. Rev. Biochem. Molec. Biol. 2010, 45, 185-198.
44. Gill, S.; Stevenson, J.; Kristiana, I.; Brown, A.J. Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab. 2011, 13, 260-273.
45. Thomas, S.; Fell, D.A. The role of multiple enzyme activation in metabolic flux control. Adv. Enzym. Regul. 1998, 38, 65-85. (Pubitemid 28381384)
46. Turley, S.D.; Schwarz, M.; Spady, D.K.; Dietschy, J.M. Gender-related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low- and high-cholesterol diets. Hepatology 1998, 28, 1088-1094. (Pubitemid 28450271)
47. Plat, J.; de Jong, A.; Volger, O.L.; Princen, H.M.; Mensink, R.P. Preferential campesterol incorporation into various tissues in apolipoprotein E&z.ast;3-Leiden mice consuming plant sterols or stanols. Metabolism 2008, 57, 1241-1247.
48. Cheema, S.K.; Cikaluk, D.; Agellon, L.B. Dietary fats modulate the regulatory potential of dietary cholesterol on cholesterol 7 alpha-hydroxylase gene expression. J. Lipid. Res. 1997, 38, 315-323. (Pubitemid 27118044)
49. Schaffer, R.; Sniegoski, L.T.; Welch, M.J.; White, V.E.; Cohen, A.; Hertz, H.S.; Mandel, J.; Paule, R.C.; Svensson, L.; Bjorkhem, I.; et al. Comparison of two isotope dilution/mass spectrometric methods for determination of total serum cholesterol. Clin. Chem. 1982, 28, 5-8. (Pubitemid 12209739)
50. Sharpe, L.J.; Brown, A.J. Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl- CoA reductase (HMGCR). J. Biol. Chem. 2013, doi:10.1074/jbc.R113.479808.
51. Fitzky, B.U.; Moebius, F.F.; Asaoka, H.; Waage-Baudet, H.; Xu, L.; Xu, G.; Maeda, N.; Kluckman, K.; Hiller, S.; Yu, H.; et al. 7-Dehydrocholesterol- dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J. Clin. Invest. 2001, 108, 905-915. (Pubitemid 32880299)
52. Yang, C.; McDonald, J.G.; Patel, A.; Zhang, Y.; Umetani, M.; Xu, F.; Westover, E.J.; Covey, D.F.; Mangelsdorf, D.J.; Cohen, J.C.; et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J. Biol. Chem. 2006, 281, 27816-27826. (Pubitemid 44414494)
53. Belic, A.; Pompon, D.; Monostory, K.; Kelly, D.; Kelly, S.; Rozman, D. An algorithm for rapid computational construction of metabolic networks: a cholesterol biosynthesis example. Comput. Biol. Med. 2013, 43, 471-480.
54. Kowdley, K.V. Ursodeoxycholic acid therapy in hepatobiliary disease. Am. J. Med. 2000, 108, 481-486. (Pubitemid 30214200)
55. Nie, B.; Park, H.M.; Kazantzis, M.; Lin, M.; Henkin, A.; Ng, S.; Song, S.; Chen, Y.; Tran, H.; Lai, R.; et al. Specific bile acids inhibit hepatic fatty acid uptake in mice. Hepatology 2012, 56, 1300-1310.
56. Hofmann, A.F. The enterohepatic circulation of bile acids in mammals: Form and functions. Front. Biosci. 2009, 14, 2584-2598.
57. Kosir, R.; Acimovic, J.; Golicnik, M.; Perse, M.; Majdic, G.; Fink, M.; Rozman, D. Determination of reference genes for circadian studies in different tissues and mouse strains. BMC Mol. Biol. 2010, 11, 60.
58. Hellemans, J.; Mortier, G.; De Paepe, A.; Speleman, F.; Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome. Biol. 2007, 8, R19.
59. Vandesompele, J.; De Preter, K.; Pattyn, F.; Poppe, B.; Van Roy, N.; De Paepe, A.; Speleman, F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome. Biol. 2002, 3, R0034.1-R0034.11.
60. Acimovic, J.; Lovgren-Sandblom, A.; Monostory, K.; Rozman, D.; Golicnik, M.; Lutjohann, D.; Bjorkhem, I. Combined gas chromatographic/mass spectrometric analysis of cholesterol precursors and plant sterols in cultured cells. J. Chromatogr. B 2009, 877, 2081-2086.
61. Min, H.K.; Kapoor, A.; Fuchs, M.; Mirshahi, F.; Zhou, H.; Maher, J.; Kellum, J.; Warnick, R.; Contos, M.J.; Sanyal, A.J. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012, 15, 665-674.
62. Wouters, K.; van Gorp, P.J.; Bieghs, V.; Gijbels, M.J.; Duimel, H.; Lutjohann, D.; Kerksiek, A.; van Kruchten, R.; Maeda, N.; Staels, B.; et al. Dietary cholesterol, Rather than liver steatosis, Leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008, 48, 474-486.
63. Mari, M.; Caballero, F.; Colell, A.; Morales, A.; Caballeria, J.; Fernandez, A.; Enrich, C.; Fernandez-Checa, J.C.; Garcia-Ruiz, C. Mitochondrial free cholesterol loading sensitizes to TNFand Fas-mediated steatohepatitis. Cell Metab. 2006, 4, 185-198. (Pubitemid 44307975)
64. Rozman, D.; Waterman, M.R. Lanosterol 14alpha-demethylase (CYP51) and spermatogenesis. Drug Metab. Dispos. 1998, 26, 1199-1201.